Literature DB >> 30081390

Therapeutic effects of mobile-based text message reminders for medication adherence in bipolar I disorder: Are they maintained after intervention cessation?

Vikas Menon1, Nivedhitha Selvakumar2, Shivanand Kattimani3, Chittaranjan Andrade4.   

Abstract

Mobile phone short messaging service (SMS) reminders may be a low-cost method for promoting medication adherence. Our objective was to determine whether text SMS reminders improve medication adherence in patients with bipolar I disorder even after discontinuation of the intervention. Participants were stable adult bipolar I disorder outpatients on maintenance medication who were randomized to receive treatment as usual (TAU; n = 70) or TAU plus twice-weekly medication reminders by SMS (n = 62) for 3 months. Rater-blinded assessments of medication adherence, treatment attitudes, and quality of life (QoL) were obtained at baseline, at the 3-month intervention endpoint, and at a 3-month post-intervention follow up during which both groups received TAU. Intent-to-treat analyses were conducted on the full randomized sample. The clinical trial protocol was registered with the Clinical Trials Registry of India (CTRI) (CTRI/2016/07/007101). The SMS intervention improved medication adherence and attitudes towards medication at the end of the treatment phase; these benefits were maintained for medication adherence but not for attitudes towards medication at the end of the follow-up phase. The SMS intervention did not improve QoL outcomes. These findings indicate that biweekly SMS reminders improve medication adherence and the benefits persist for at least 3 months after the SMS reminders are discontinued. The SMS reminders do not affect attitudes towards treatment or QoL.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Asia; Behavior maintenance; Bipolar disorder; Medication adherence; Mobile phone; Text message reminders

Mesh:

Year:  2018        PMID: 30081390     DOI: 10.1016/j.jpsychires.2018.07.013

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  6 in total

1.  Development of an Emotion-Sensitive mHealth Approach for Mood-State Recognition in Bipolar Disorder.

Authors:  Henning Daus; Timon Bloecher; Ronny Egeler; Richard De Klerk; Wilhelm Stork; Matthias Backenstrass
Journal:  JMIR Ment Health       Date:  2020-07-03

Review 2.  Mobile health applications for disease screening and treatment support in low-and middle-income countries: A narrative review.

Authors:  Ernest Osei; Tivani P Mashamba-Thompson
Journal:  Heliyon       Date:  2021-03-31

3.  Methylphenidate augmentation of escitalopram to enhance adherence to antidepressant treatment: a pilot randomized controlled trial.

Authors:  Martin P Paulus; Rayus Kuplicki; Teresa A Victor; Hung-Wen Yeh; Sahib S Khalsa
Journal:  BMC Psychiatry       Date:  2021-11-19       Impact factor: 3.630

4.  Residual Effect of Texting to Promote Medication Adherence for Villagers with Schizophrenia in China: 18-Month Follow-up Survey After the Randomized Controlled Trial Discontinuation.

Authors:  Yiyuan Cai; Wenjie Gong; Wenjun He; Hua He; James P Hughes; Jane Simoni; Shuiyuan Xiao; Stephen Gloyd; Meijuan Lin; Xinlei Deng; Zichao Liang; Bofeng Dai; Jing Liao; Yuantao Hao; Dong Roman Xu
Journal:  JMIR Mhealth Uhealth       Date:  2022-04-19       Impact factor: 4.947

Review 5.  Digital interventions for people living with non-communicable diseases in India: A systematic review of intervention studies and recommendations for future research and development.

Authors:  Md Mahbub Hossain; Samia Tasnim; Rachit Sharma; Abida Sultana; Araish Farzana Shaik; Farah Faizah; Ravneet Kaur; Madhuri Uppuluri; Mitali Sribhashyam; Sudip Bhattacharya
Journal:  Digit Health       Date:  2019-12-16

Review 6.  The Use of Text Messaging to Improve Clinical Engagement for Individuals With Psychosis: Systematic Review.

Authors:  Jessica D'Arcey; Joanna Collaton; Nicole Kozloff; Aristotle N Voineskos; Sean A Kidd; George Foussias
Journal:  JMIR Ment Health       Date:  2020-04-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.